CLSD
Clearside Biomedical
CLSD
CLSD
Delisted
CLSD was delisted on the 28th of November, 2025.
48 hedge funds and large institutions have $12.8M invested in Clearside Biomedical in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
29% less capital invested
Capital invested by funds: $17.9M → $12.8M (-$5.15M)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Holders
48
Holding in Top 10
–
Calls
$194K
Puts
$64K
Top Buyers
| 1 | +$624K | |
| 2 | +$252K | |
| 3 | +$206K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$159K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$130K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$2.78M | |
| 3 | -$253K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$80.8K |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$52K |